OncXerna Therapeutics Alternatives & Competitors

12 companies similar to OncXerna Therapeutics — Advancing a new paradigm of precision oncology with a RNA-based approach to matc...

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...

San Diego, United States

Biopharma Biotechnology +1

Lisata Therapeutics, Inc.

Targeted Therapy Delivered

39 Acquired $4.44M

United States

Biotechnology Health and Wellness +1

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 Post-IPO Equity $28.05M

Newton, United States

Biotechnology Health Care +1

Anchiano Therapeutics

Dedicated to the discovery, development, and commercialization of novel targeted therapies...

1 Post-IPO Equity $42.00M

Cambridge, United States

Biotechnology Health Care +1

Track all OncXerna Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

F-star Therapeutics

Innovation focused private biotech dedicated to delivering next-generation multispecific a...

12 Post-IPO Equity $122.90M

Cambridge, United Kingdom

Biopharma Biotechnology +1

Genmab

Differentiated human antibody therapeutics for the treatment of cancer

2981 IPO $2.28B

Denmark

Biotechnology Pharmaceutical

Acrivon Therapeutics, Inc.

77 Post-IPO Equity $245.50M

United States

Biotechnology Health Care +1

Ikena Oncology (Merged with ImageneBio)

Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for mo...

14 Post-IPO Equity $209.00M

Boston, United States

Biotechnology Health Care +1

Phoenix Molecular Designs

A clinical stage biopharmaceutical company designing precise cancer therapeutics to addres...

22 Series A $12.35M

San Diego, United States

Biotechnology Health Care +1

Merus N.V.

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community...

185 Post-IPO Equity $1.04B

Utrecht, The Netherlands

Biotechnology Health Care +1

GLG Pharma

Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's...

3 Venture round

Jupiter, United States

Biotechnology Health Care +1

Scorpion Therapeutics

Pioneering the Next Generation of Precision Oncology

16 Series C $420.00M

Biotechnology Health Care +1

About OncXerna Therapeutics

OncXerna Therapeutics is a clinical stage precision medicine oncology company founded in 2018, with a mission to advance a new paradigm of precision oncology using a RNA-based approach. The company's innovative precision medicine platform, Xerna™, leverages artificial intelligence technologies and RNA expression-based...

Taxonomy

Precision Medicine, Oncology, RNA-based Biomarkers, Clinical-stage Therapies, Bispecific Antibodies, Drug Development, Cancer Treatment, Clinical Trials, Biopharmaceutical, Biomarker Platform, Precision Oncology, Tumor Microenvironments, Therapeutics, RNA Expression

Frequently Asked Questions

Companies similar to OncXerna Therapeutics include Antharis Therapeutics, Inc., Lisata Therapeutics, Inc., TransCode Therapeutics, Inc., Anchiano Therapeutics, F-star Therapeutics. They work in Biotechnology and Health Care and share OncXerna Therapeutics 's focus on cancer treatment, clinical trials and precision medicine.

Bounce Watch lists 12 companies that share OncXerna Therapeutics 's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches OncXerna Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

OncXerna Therapeutics Profile Antharis Therapeutics, Inc. Alternatives Lisata Therapeutics, Inc. Alternatives TransCode Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at OncXerna Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 25 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.